Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/DAIICHI-SANKYO-CO-LTD-6498062/news/Trastuzumab-Deruxtecan-Type-II-Variation-Application-Validated-by-EMA-for-the-Treatment-of-HER2-Posi-36898697/?utm_source=whatsapp&utm_medium=social&utm_campaign=share